These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10830108)

  • 1. Structural and functional modelling of von Willebrand factor type A domains in complement and coagulation.
    Perkins SJ; Hinshelwood J; Edwards YJ; Jenkins PV
    Biochem Soc Trans; 1999 Dec; 27(6):815-20. PubMed ID: 10830108
    [No Abstract]   [Full Text] [Related]  

  • 2. von Willebrand disease: pathogenesis, classification, and management.
    Murray EW; Lillicrap D
    Transfus Med Rev; 1996 Apr; 10(2):93-110. PubMed ID: 8721967
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolution of von Willebrand factor A (VWA) domains.
    Tuckwell D
    Biochem Soc Trans; 1999 Dec; 27(6):835-40. PubMed ID: 10830113
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomedicine. Contact--how platelets touch von Willebrand factor.
    Sadler JE
    Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
    [No Abstract]   [Full Text] [Related]  

  • 5. Something new about type Normandy von Willebrand disease (type 2N VWD)?
    Mazurier C
    Thromb Haemost; 2004 Jul; 92(1):1-2. PubMed ID: 15213838
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutations.
    O'Brien LA; Sutherland JJ; Weaver DF; Lillicrap D
    J Thromb Haemost; 2005 Apr; 3(4):796-7. PubMed ID: 15842374
    [No Abstract]   [Full Text] [Related]  

  • 8. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations.
    Sutherland JJ; O'Brien LA; Lillicrap D; Weaver DF
    J Mol Model; 2004 Aug; 10(4):259-70. PubMed ID: 15322948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease.
    Enayat S; Ravanbod S; Rassoulzadegan M; Jazebi M; Tarighat S; Ala F; Emsley J; Othman M
    Thromb Haemost; 2012 Nov; 108(5):946-54. PubMed ID: 23014764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor.
    Zhang Q; Zhou YF; Zhang CZ; Zhang X; Lu C; Springer TA
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9226-31. PubMed ID: 19470641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [von Willebrand factor and von Willebrand disease].
    Matsui T; Hamako J
    Rinsho Ketsueki; 2016; 57(10):2113-2123. PubMed ID: 27795521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels.
    Davies JA; Collins PW; Hathaway LS; Bowen DJ
    Acta Haematol; 2009; 121(2-3):98-101. PubMed ID: 19506354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fine structure of von Willebrand factor multimers and type IIA von Willebrand disease.
    Lynch DC
    Ann N Y Acad Sci; 1991; 614():138-52. PubMed ID: 2024881
    [No Abstract]   [Full Text] [Related]  

  • 18. Autosomal dominant von Willebrand disease type 2M.
    Hermans C; Batlle J
    Acta Haematol; 2009; 121(2-3):139-44. PubMed ID: 19506360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease.
    Hommais A; Stépanian A; Fressinaud E; Mazurier C; Pouymayou K; Meyer D; Girma JP; Ribba AS
    Thromb Haemost; 2006 May; 95(5):776-81. PubMed ID: 16676067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.
    Rastegar-Lari G; Ajzenberg N; Ribba AS; Vereycken-Holler V; Legendre P; Villoutreix B; Meyer D; Baruch D
    Thromb Haemost; 2001 Dec; 86(6):1459-65. PubMed ID: 11776314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.